CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms

NCT06593145 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia (ALL)
Mantle Cell Lymphoma (MCL)
Large B-cell Lymphoma

Interventions

BIOLOGICAL: FCTX-CL19-1 (Tarcidomgen Kimleucel)

Sponsor

FamiCordTx